Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia
M. Restrepo (San Antonio, United States of America), S. Pascual-Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), M. Carugati (Milan, Italy), A. Rodriguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Sevilla, Spain), G. Sotgiu (Sassari, Italy), M. Kolditz (Dresden, Germany), S. Aliberti (Milan, Italy), G. Investigators (San Antonio, United States of America)
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Restrepo (San Antonio, United States of America), S. Pascual-Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), M. Carugati (Milan, Italy), A. Rodriguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Sevilla, Spain), G. Sotgiu (Sassari, Italy), M. Kolditz (Dresden, Germany), S. Aliberti (Milan, Italy), G. Investigators (San Antonio, United States of America). Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia. 3094
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: